ICI 118,551 hydrochloride

CAS No. 72795-01-8

ICI 118,551 hydrochloride ( ICI 118551 hydrochloride )

Catalog No. M24738 CAS No. 72795-01-8

ICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ICI 118,551 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    ICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).
  • Description
    ICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).
  • Synonyms
    ICI 118551 hydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    β2 receptor;β1 receptor;β3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72795-01-8
  • Formula Weight
    313.9
  • Molecular Formula
    C17H28ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 20 mg/mL (63.72 mM; Need ultrasonic) H2O : 11 mg/mL (35.05 mM; Need ultrasonic)
  • SMILES
    CC1=C(CCC2)C2=C(OC[C@H](O)[C@@H](C)NC(C)C)C=C1.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yasuda G, et al. The beta 1- and beta 2-adrenoceptor subtypes in cultured rat inner medullary collecting duct cells. Am J Physiol. 1996 Sep;271(3 Pt 2):F762-9.
molnova catalog
related products
  • Acetyl hexapeptide 3...

    Acetyl hexapeptide 38, breast enhancement peptide, is a kind of acetylated hexapeptide, can significantly stimulate the use of the site of fat synthesis, increase the volume of the chest or cheek, shape the perfect body

  • Z-Phe-Ala-NH2

    Heterocyclic Organic Compound

  • Grandifloroside

    Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).